CHANGES IN MACULAR THICKNESS AFTER PART TIME OCCLUSION IN CHILDREN WITH AMBLYOPIA USING OPTICAL COHERENCE TOMOGRAPHY (OCT)

Document Type : Original Article

Authors

Department of Ophthalmology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

Abstract

Background: Amblyopia is the commonest childhood vision disorder, most children with amblyopia require refractive correction as well as patching; Evidences for direct retinal changes in amblyopic eyes are still inconclusive and controversial.
Objectives: To detect changes in the macula by macular Optical Coherence Tomography (OCT) after part time occlusion in children with amblyopia.
Patients and Methods: Arandomised non controlled study included forty child suffering amblyopia in this study. Best corrected visual acuity (BCVA: 0.1- 0.5) were recruited and treated with refractive correction, and part time occlusion (6 hours/day) for one week per year. BCVA and macular thickness were measured by OCT before and after treatment. Factorial repeated-measures analysis of variance was performed to determine the macular thickness in amblyopic eyes changed after amblyopia treatment.
Results: The mean age of children was 8.57±2.52 years. There was a statistically significant difference in the central macular thickness pre & post amblyopia treatment. There was no statistically significant difference for the other macular thickness parameters except for superior quadrant of parapovea where the difference was significantly significant.
Conclusion: The mean of central macular thickness and superior quadrant of parapovea increased after part time occlusion treatment compared to pretreatment. No significant difference in average macular thickness, (nasal, temporal, inferior) parapovea, perifovea, retinal nerve fiber layer (RNFL) thickness and ganglion cell layer (GCL) before and after treatment.

Keywords


CHANGES IN MACULAR THICKNESS AFTER PART TIME OCCLUSION IN CHILDREN WITH AMBLYOPIA USING OPTICAL COHERENCE TOMOGRAPHY (OCT)

By

 

Mohamed Zakaria Eid, Ahmed Mahmoud Amin and Mahmoud El-Sayed Mohamed

Department of Ophthalmology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

Correspondence to: Mahmoud Elsayed Mohamed.

Email: mahmoudsalem3330@gmail.com, Telephone: 01009613330

ABSTRACT

Background: Amblyopia is the commonest childhood vision disorder, most children with amblyopia require refractive correction as well as patching; Evidences for direct retinal changes in amblyopic eyes are still inconclusive and controversial.

Objectives: To detect changes in the macula by macular Optical Coherence Tomography (OCT) after part time occlusion in children with amblyopia.

Patients and Methods: Arandomised non controlled study included forty child suffering amblyopia in this study. Best corrected visual acuity (BCVA: 0.1- 0.5) were recruited and treated with refractive correction, and part time occlusion (6 hours/day) for one week per year. BCVA and macular thickness were measured by OCT before and after treatment. Factorial repeated-measures analysis of variance was performed to determine the macular thickness in amblyopic eyes changed after amblyopia treatment.

Results: The mean age of children was 8.57±2.52 years. There was a statistically significant difference in the central macular thickness pre & post amblyopia treatment. There was no statistically significant difference for the other macular thickness parameters except for superior quadrant of parapovea where the difference was significantly significant.

Conclusion: The mean of central macular thickness and superior quadrant of parapovea increased after part time occlusion treatment compared to pretreatment. No significant difference in average macular thickness, (nasal, temporal, inferior) parapovea, perifovea, retinal nerve fiber layer (RNFL) thickness and ganglion cell layer (GCL) before and after treatment.

Keywords: Amblyopia, occlusion therapy, macular changes.

 

 

INTRODUCTION

     Strabismic amblyopia results from abnormal binocular interaction where there is continued monocular suppression of the deviating eye. Bilateral ametropic amblyopia results from high symmetrical refractive errors, usually herpermetropia. Meridional amblyopia results from image blur in one meridian, e.g. uncorrected astigmatism. In absence of organic lesion, a difference in best corrected visual acuity of two snellen lines or more (or < 1 log unit) is indicative of amblyopia (Bowling , 2016).

     The part-time occlusion treatment in school-aged amblyopes, which had been carried out after school hours, was successful and the effect was sustained in most cases (Hwang et al., 2010).

     Optical coherence tomography (OCT) uses a continuously emitting optically coherent laser diode centered at 850 nm and focused at the retina. The super-luminance low-coherence diode emits light with a 20 to 25 nm band width. For thickness measurements, the time delay of reflected or backscattered light is determined using coherence interferometry (Liu et al., 2010).

     Evidences for direct retinal changes in amblyopic eyes are still inconclusive and controversial, although electroretinograms elicited by patterned stimuli in humans with various types of amblyopia were found to be significantly reduced. Studies using optical coherence tomography (OCT) imaging of the retina have not produced definite results (Sapkota et al., 2014).

     The purpose of this study was to determine macular changes by OCT after part time occlusion treatment in children with amblyopia.

PATIENTS AND METHODS

     Arandomised non controlled study included forty child aged 5–12 years at the outpatient clinic, El Mattarya Teaching Hospital and Al-Hussein University Hospital, Cairo, Egypt. The study protocol was adhered to the tents of declaration of Heliniski and was approved by the ethical committee of the Faculty of Medicine, Al-Azhar University.

 

Inclusion criteria:

     We included in the study children with BCVA in the amblyopic eye was 0.1 to 0.5 by decimal system after conversion from snellen chart; Intereye acuity difference was 2 Snellen lines. No amblyopia treatment (other than spectacles) in the past month and no more than 1 month of amblyopia treatment in the past 6 months.

Exclusion criteria:

     In the study we excluded children with history of seizures, prematurity (birth weight < 1500 g or gestational age <34 weeks), mental retardation, ocular anomalies or pathologies, fundus lesions, nystagmus, glaucoma, organic lesions and history of intraocular surgery.

     The patient hos  undergon complete eye examination ,BCVA testing with Snellen chart including crowding phenomenon and neutral denisty filter before and after part time occlusion treatment with patching (6 hours/day) for one week per year, evaluation of ocular duction and versions, alternate prism cover test for diagnosis and measurement of eye deviation, cycloplegic refraction (automated) 45 min after installing cyclopentolate 1%, one drop 10 min apart, anterior segment examination by slit lamp, IOP measurement with air puff tonometer, funduscopy to rule out optic nerve and macular lesions . 3D retinal topography of amblyopic eye of each participante was done before and after patching using topcon 3d oct 2000 fa plus machine (made in Japan).

     The mean of these values, as calculated by preloaded software was used to calculate the average macular thickness, central macular thickness, total volume, parafoveal quadrants, perifoveal quadrants, RNFL thickness and GCL.

     Recorded data were analyzed using the statistical package for social sciences, version 20.0 (SPSS Inc., Chicago, Illinois, USA). Quantitative data were expressed as mean± standard deviation (SD). Qualitative data were expressed as frequency and percentage. Paired sample t-test of significance was used when comparing between related samples. The confidence interval was set to 95% and the margin of error accepted was set to 5%. So, the Probability (p-value) was considered significant as the following: P-value <0.05 was considered significant, P-value <0.001 was considered as highly significant and P-value >0.05 was considered insignificant.


RESULTS

 

 

     The present study included 19 (47.5%) females and 21 (52.5%) males. The mean age was 8.57±2.52. The main complain in the study group was diminution of vision in 32 patient (80%), and eye deviation in 8 patients (20%). Considering refraction of the study group, myopic patients were 26(65%) with a mean -7.07±4.55, While hyperopic patients was 14(35%) with a mean 3.93±1.96 (Table 1).


Table (1): Refraction distribution of the study group

Refraction

No.

%

Range

Mean±SD

Myopia

26

65.0%

-16.75 to -1

-7.07±4.55

Hypermetropia

14

35.0%

1 to 8

3.93±1.96

Total

40

100.0%

-16.75 to 8

-3.22±6.51

 

 

     In the study group, the right eye was amblyopic in 21(52.5%) patients, while the left eye was the affected in 19 (47.5%) patients. Considering BCVA, we found a statistically significant difference when compared pre - and post - amblyopia treatment (Table 2).


 

Table (2): Comparison between BCVA before and after treatment

BCVA

Range

Mean±SD

Mean Diff.

Mann-Whitney test

 

p-value

Before

0.1-0.5

0.27±0.12

0.22

 

<0.001

After

0.1-1

0.49±0.20

 

 

     Fundus examination was normal in 32 (80%), tigroid in 4 (10%), tigroid with tilted disc in 3 (7.5%) and tigroid with mylenated nerve fibers in 1 (2.5%). Two of our patients suffered alternating exotropia (5%) and 8 patients suffered esotropia (fully accommodative) (20%). There was a statistically significant difference in the central thickness when compared pre - and post - amblyopia treatment, while the difference was statistically non-significant in average macular thickness and total volume   There was a statistically significant difference in the superior quadrant of parafovea when compared pre - and post - amblyopia treatment, while the difference was statistically non-significant in other quadrants of parafovea There were statistically non-significant differences in all quadrants when compared pre - and post - amblyopia treatment (Table 3). Considering RNFL thickness, GCL+ and GCL++, we found statistically non-significant differences when compared pre - and post - amblyopia treatment (Table 3).

 

 

Table (3): Pre-treatment VS. post-treatment OCT macula

Treatment

parameters 

Before Treatment

After Treatment

Paired Sample t-test

Mean Diff.

p-value

 

 

 

 

 

Average Thickness

267.65±20.60

268.40±21.28

0.750

0.525

Central Thickness

188.30±28.33

195.08±33.88

6.780

0.038*

Total Volume

7.49±0.81

7.61±0.62

0.120

0.118

Parafovea Macula

 

 

 

 

Nasal

294.20±24.95

297.63±23.45

3.430

0.064

Superior

292.25±26.72

297.45±23.23

5.200

0.049*

Temporal

281.20±21.55

285.13±27.16

3.930

0.216

Inferior

291.65±25.15

292.53±24.83

0.880

0.666

Perifovea Macula

 

 

 

 

Nasal

277.20±30.65

277.28±32.45

0.080

0.938

Superior

264.83±20.44

264.70±22.81

-0.130

0.942

Temporal

250.00±23.52

251.60±23.74

1.600

0.237

Inferior

258.70±28.17

261.33±25.93

2.630

0.479

 

 

 

 

 

RNFL Thickness

31.65±2.18

32.00±2.31

0.350

0.264

GCL+

71.00±3.49

71.18±3.57

0.180

0.138

GCL++

102.03±4.25

102.78±4.21

0.750

0.235

 

 

DISCUSSION

     The mainstay treatment for amblyopia is occlusion of the better eye by an opaque patch (“patching”), to promote visual function. Part-time occlusion, defined as occlusion for 2-6 hours per day, has been shown to achieve results similar to those of prescribed full-time occlusion. The relative duration of patch-on and patch-off intervals should reflect the degree of amblyopia, maintenance patching of 1- 2 hours per day is often prescribed to prevent recurrence of amblyopia after successful patching.

     By examination of forty amblyopogenic patients, we performed pretreatment OCT macula, part time occlusion treatment (6 hours/day) for one week per year and post treatment OCT macula.

     In our study, there was a significant increase in the mean of central macular thickness and superior quadrant of parafovea after part time occlusion treatment compared to pretreatment. No significant difference in average macular thickness, (nasal, temporal, inferior) parafovea, perifovea, RNFL thickness, GCL+ and GCL++ before and after treatment.

     Tugcu et al., (2014) studied macular thickness in the amblyopic eyes and reported no difference in macular thickness. Chen et al., (2013) reported no significant thickness difference in any region of the macula. Chun-Hsiu (2018) reported no difference was found in the macular and choroidal thicknesses between the persistent and recovered amblyopic eyes. Huynh et al., (2009) found that both foveal minimum thickness and average foveal thickness were greater in the amblyopic eyes with high myopia than in the normal fellow eyes. In contrast, both inner and outer macular thickness were thinner in the amblyopic eyes compared with that of the fellow eyes. Pang et al., (2015) reported that amblyopic eyes in children with myopic anisometropia had thicker foveae and thinner peripheral maculae compared to the fellow eyes before amblyopia treatment. Central maculae tended to be thinner following amblyopia treatment with no changes in peripheral macula. Kavitha et al., (2019) reported that macular thickness and foveal thickness which were more in amblyopic eyes as compared to normal fellow eyes and normal eyes of normal children, decreased with improvement in BCVA after occlusion therapy. However, there was no difference in RNFL thickness between amblyopic eyes and normal fellow eyes and normal eyes of normal children before and after occlusion therapy.

     The variations in results of these reports are probably due to different study populations, defining criteria, type of amblyopia, different instruments used in measuring and co-existent factors like refractive errors.

CONCLUSION

     The mean of central macular thickness and superior quadrant of parapovea increased after part time occlusion treatment compared to pretreatment. No significant difference in average macular thickness, (nasal, temporal, inferior) parapovea, perifovea, RNFL thickness and GCL before and after treatment.

REFERENCES

  1. Bowling B (2016): Kanski's clinical ophthalmology 8th edition, pbl Elsevier USA, chapter 18, strabismus, pp. 737-743.
  2. Chen W, Chen J, Huang J, Xu J, Zhang F and Lu F (2013): Comparison of macular and retinal nerve fiber layer thickness in untreated and treated binocular amblyopia. Curr Eye Res., 38:1248–1254.
  3. Chun-Hsiu L, Sherine JO, Chung-Ying H, Wei-Chi W, Ling-Yuh K and Meng-Ling Y (2018): Macular Thickness, Foveal Volume, and Choroidal Thickness in Amblyopic Eyes and Their Relationships to the Treatment Outcome. J Ophthalmol.; 2018: 1967621.
  4. Huynh SC, Samarawickrama C and Wang XY (2009): Macular and nerve fiber layer thickness in amblyopia: the Sydney Childhood Eye Study. Ophthalmology, 116:1604–1609.
  5. Hwang DJ, Kim YJ and Lee JY (2010): Effect and sustainability of part-time occlusion therapy for patients with anisometropic amblyopia aged ≥8 years; British Journal of Ophthalmology, 94:1160-1164.
  6. Kavitha V, Heralgi MM, Harishkumar PD, Harogoppa S, Shivaswamy H M and Geetha H (2019): Analysis of macular, foveal, and retinal nerve fiber layer thickness in children with unilateral anisometropic amblyopia and their changes following occlusion therapy. Indian J Ophthalmol, 67:1016-22.
  7. Liu H, Zhong L and Zhou X (2010): Macular abnormality observed by OCT in children with amblyopia failing to achieve normal visual acuity after long-term treatment. J Pediatr Ophthalmol Strabismus, 47: 17—23.
  8. Pang Y, Frantz KA, Block S, Goodfellow GW and Allison C (2015): Effect of amblyopia treatment on macular thickness in eyes with myopic anisometropic amblyopia. Invest Ophthalmol Vis Sci., 56:2677–2683.
  9. Sapkota C, Alves S and Pina S (2014): Comparison of macular thickness and volume in amblyopic children using time domain optical coherence tomography. Ophthalmologia, 36:231—236.
  10. Tugcu B, Araz-Ersan B and Erdogan ET (2014): Structural and functional comparison of the persistent and resolved amblyopia. Doc Ophthalmol., 128:101–109.

 


تغیرات فی سمک الماقولة بعد التغطیة الجزئیة للعین فی حالات الکسل الوظیفی باستخدام التصویر المقطعی الضوئی المترابط

محمد زکریا عید،  أحمد محمود أمین، محمود السید محمد سالم

قسم طب وجراحة العیون، کلیة الطب (القاهرة)، جامعة الأزهر

خلفیة البحث: الکسل الوظیفی للعین هو أکثر عیوب الأبصار انتشارا فی مرحلة الطفولة, معظم الأطفال الذین یعانون من کسل وظیفی یحتاجون لاصلاح خلل الانکسار بالاضافة الی تغطیة العین, الدلائل علی وجود تغیرات بشبکیة العین فی الأعین التی بها کسل وظیفی مازالت غیر حاسمة و محل جدل.

الهدف من البحث: قیاس سمک أجزاء الماقولة بإستخدام التصویر المقطعى الضوئى فى الأعین التى بها کسل وظیفى قبل وبعد العلاج بتغطیة العین لجزء من الوقت.

المرضى وطرق البحث: دراسة عشوائیة غیر محکومة تضمنت أربعین طفل یعانون من الکسل الوظیفی للعین ( أفضل تصحیح لحدة الابصار 0.1 – 0.5 ) تم علاجهم باصلاح خلل الانکسار والتغطیة الجزئیه للعین (6 ساعات/الیوم) لمدة اسبوع عن کل عام من عمر الطفل, افضل تصحیح لحدة الابصار وسمک أجزاء الماقولة (بجهاز التصویر المقطعی الضوئی) تم قیاسهم قبل وبعد العلاج. تم اجراء تحلیل متکرر للفرق فی للقیاسات لتحدید اذا کان هناک تغییر فی سمک مرکز الابصار بعد العلاج.

نتائج البحث: متوسط اعمار الاطفال یتراوح بین 5-12 سنة. هناک تغییر ذات دلالة احصائیة فی متوسط سمک النقرة بمرکز الابصار قبل وبعد العلاج, ولا یوجد تغییر ذو  دلالة إحصائیة فی باقی أجزاء ماقولة العین ماعدا الجزء العلوی

الاستنتاج: هناک زیادة فی متوسط سمک النقرة والجزء العلوی من مجاورالماقولة بعد العلاج بالتغطیة الجزئیة للعین  ولکن لا یوجد إختلاف ذو اهمیة فی باقی أجزاء الماقولة وسمک طبقة الألیاف العصبیة بالشبکیة و طبقة الخلایا العقدیة بعد العلاج.

  1. REFERENCES

    1. Bowling B (2016): Kanski's clinical ophthalmology 8th edition, pbl Elsevier USA, chapter 18, strabismus, pp. 737-743.
    2. Chen W, Chen J, Huang J, Xu J, Zhang F and Lu F (2013): Comparison of macular and retinal nerve fiber layer thickness in untreated and treated binocular amblyopia. Curr Eye Res., 38:1248–1254.
    3. Chun-Hsiu L, Sherine JO, Chung-Ying H, Wei-Chi W, Ling-Yuh K and Meng-Ling Y (2018): Macular Thickness, Foveal Volume, and Choroidal Thickness in Amblyopic Eyes and Their Relationships to the Treatment Outcome. J Ophthalmol.; 2018: 1967621.
    4. Huynh SC, Samarawickrama C and Wang XY (2009): Macular and nerve fiber layer thickness in amblyopia: the Sydney Childhood Eye Study. Ophthalmology, 116:1604–1609.
    5. Hwang DJ, Kim YJ and Lee JY (2010): Effect and sustainability of part-time occlusion therapy for patients with anisometropic amblyopia aged ≥8 years; British Journal of Ophthalmology, 94:1160-1164.
    6. Kavitha V, Heralgi MM, Harishkumar PD, Harogoppa S, Shivaswamy H M and Geetha H (2019): Analysis of macular, foveal, and retinal nerve fiber layer thickness in children with unilateral anisometropic amblyopia and their changes following occlusion therapy. Indian J Ophthalmol, 67:1016-22.
    7. Liu H, Zhong L and Zhou X (2010): Macular abnormality observed by OCT in children with amblyopia failing to achieve normal visual acuity after long-term treatment. J Pediatr Ophthalmol Strabismus, 47: 17—23.
    8. Pang Y, Frantz KA, Block S, Goodfellow GW and Allison C (2015): Effect of amblyopia treatment on macular thickness in eyes with myopic anisometropic amblyopia. Invest Ophthalmol Vis Sci., 56:2677–2683.
    9. Sapkota C, Alves S and Pina S (2014): Comparison of macular thickness and volume in amblyopic children using time domain optical coherence tomography. Ophthalmologia, 36:231—236.
    10. Tugcu B, Araz-Ersan B and Erdogan ET (2014): Structural and functional comparison of the persistent and resolved amblyopia. Doc Ophthalmol., 128:101–109.